FindTrial
Sign In

Effectiveness of oral zinc supplementation for term neonates with jaundice receiving phototherapy

Effectiveness of oral zinc supplementation for term neonates with hyperbilirubinemia receiving phototherapy : A Randomized controlled trial. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094993
Enrollment
90
Registered
2025-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P84- Other problems with newborn

Interventions

Intervention1: Oral zinc supplementation: Oral zinc supplementation of 5mg/day in newborn with hyperbilirubinemia requiring phototherapy for 3 days once a day Intervention2: Oral zinc supplementation

Sponsors

P ROHIT
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Neonates with hyperbilirubinemia

Exclusion criteria

Exclusion criteria: Preterm neonates Pathological hyperbilirubinemia Systematic illness Sepsis

Design outcomes

Primary

MeasureTime frame
To study the effectiveness of oral zinc supplementation in term neonates with hyperbilirubinemia requiring phototherapyTimepoint: Every 24 hr till bilirubin level falls below danger level Reports ll be compared at the end of study 3 days—

Secondary

MeasureTime frame
Duration of hospital stayTimepoint: 3 days—

Countries

India

Contacts

Public ContactDr chandru bhaskar

Aarupadai veedu medical college and hospital

chandru14885@gmail.com8317365885

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026